The DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Open accessAbstract
Background: Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia. Objective: To develop consortium statements on screening, surveillance and management of high-risk individuals with an inherited predisposition to PC. Methods: A 49-expert multidisciplinary international consortium met to discuss pancreatic screening and vote on statements. Consensus was considered reached if ≥75% agreed or disagreed. Results: There was excellent agreement that, to be successful, a screening programme should detect and treat T1N0M0 margin-negative PC and high-grade dysplastic precursor lesions (pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm). It was agreed that the following were candidates for screening: first-degree relatives (FDRs) of patients with PC from a familial PC kindred with at least two affected FDRs; patients with Peutz–Jeghers syndrome; and p16 , BRCA 2 and hereditary non-polyposis colorectal cancer (HNPCC) mutation carriers with ≥1 affected FDR. Consensus was not reached for the age to initiate screening or stop surveillance. It was agreed that initial screening should include endoscopic ultrasonography (EUS) and/or MRI/magnetic resonance cholangiopancreatography not CT or endoscopic retrograde cholangiopancreatography. There was no consensus on the need for EUS fine-needle aspiration to evaluate cysts. There was disagreement on optimal screening modalities and intervals for follow-up imaging. When surgery is recommended it should be performed at a high-volume centre. There was great disagreement as to which screening abnormalities were of sufficient concern to for surgery to be recommended. Conclusions: Screening is recommended for high-risk individuals, but more evidence is needed, particularly for how to manage patients with detected lesions. Screening and subsequent management should take place at high-volume centres with multidisciplinary teams, preferably within research protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pancreas surveillance has been recommended for individuals estimated to be at high risk of developing PDAC (5% or higher estimated lifetime risk).5-8”
From The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival (2022) · cites this paper as [5]
In the citing paper
“The US Preventive Services Task Force and other guidelines recommend against screening for pancreatic ductal adenocarcinoma in asymptomatic adults at average risk.6,53,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“All screening programmes for pancreatic ductal adenocarcinoma aim to detect and treat T1N0M0 cancers or high-grade dysplastic premalignant lesions (ie, pancreatic intraepithelial neoplasia 3 or mucinous cystic tumours with high-grade dysplasia).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“This target includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes (eg, Peutz-Jeghers syndrome, or germline mutations in the CDKN2A, BRCA2, or PALB2),6,54 and individuals with mucinous cystic lesions of the pancreas.19–21”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“However, international guidelines and a white paper on the early detection of pancreatic ductal adenocarcinoma recommend targeted screening of individuals whose lifetime risk of developing pancreatic ductal adenocarcinoma is higher than 5% (figure 1).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O’Brien, M. J., Lansdorp‐Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Self-citationInternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Tanaka, M., Chari, S. T., Adsay, V. N., Carlos, F.-D., Falconi, M., Shimizu, M., Yamaguchi, K., Yamao, K., & Matsuno, S. (2005) · Pancreatology · doi:10.1159/000090023 · Cited by 2,042
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,491
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
Self-citation
Cited by
Sorted by citations
Items 601–700 of 785
Vasen, H. F. A., Canto, M. I., & Goggins, M. (2024) · Familial Cancer · doi:10.1007/s10689-024-00404-0 · Cited by 2
Self-citationCáncer de la vía biliar y del páncreas
Díez, E. E., Higueras, F. J. Á., & Álvarez, F. C. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.03.020 · Cited by 1
Michaelson‐Cohen, R., Beeri, R., Golomb, E., & Levy‐Lahad, E. (2016) · Springer eBooks · doi:10.1007/978-3-319-19674-9_22 · Cited by 1
Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals
Labiner, A. J., Aronson, A., & Lucas, A. L. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.06.004 · Cited by 1
Pancreatic adenocarcinoma — current trends in diagnosis and treatment
Gruszczyńska, A., Kowalik, K., Hetman, K., & Modrzejewski, A. (2023) · Oncology in Clinical Practice · doi:10.5603/ocp.2023.0016 · Cited by 1
Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer
Rosner, G., Scapa, E. F., Ziv, T., Gluck, N., & Ben‐Yehoyada, M. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000668 · Cited by 2
Pan02 pancreatic tumor models carrying the GFP marker in mice
Акопов, С. Б., Snezhkov, E. V., Konovalova, M. V., Kostromina, M. A., Есипов, Р. С., & Svirshchevskaya, E. V. (2024) · Medical Immunology (Russia) · doi:10.15789/1563-0625-ppt-16858 · Cited by 1
Early Detection of Pancreatic Cancer: Recent Advancements
Konikoff, T. D., & Majumder, S. (2025) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-025-00480-w · Cited by 2
Bogdanski, A. M., Klatte, D. C. F., Laghari, S. I., Langers, A. M. J., Das, A., Bastiaansen, B. A. J., Bonsing, B. A., Dekker, E., van Hooft, J. E., Samadder, J. N., et al. (2025) · Familial Cancer · doi:10.1007/s10689-025-00512-5 · Cited by 1
Saba, H., Diwan, E. A., Sinan, H., Melki, D., Dbouk, M. H., Blackford, A. L., Chu, L. C. H., Shin, E. J., Canto, M. I., & Goggins, M. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100818 · Cited by 1
Self-citationCurrent diagnosis and treatment of pancreatic cancer
Matykiewicz, J., Dziura, R., & Głuszek, S. (2025) · Polish Journal of Surgery · doi:10.5604/01.3001.0055.4391 · Cited by 1
Carrara, S., Archibugi, L., Terrin, M., Secchettin, E., Luca, R. D., & Paiella, S. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.04.007 · Cited by 1
Pancreatic Cancer Screening and Early Detection: Where Are We Now?
Rao, S. S., Ghosh, S., Goenka, A. H., Hecht, E. M., Huang, C., Wang, Z. J., Castillo, C. F. F.-D., Chung, D. C., Chari, S. T., & Kambadakone, A. R. (2026) · Radiographics · doi:10.1148/rg.250146 · Cited by 1
PALB2 and the Risks for Cancer: Implications for Clinical Care
Smith, E. C. (2014) · Oncology nursing forum · doi:10.1188/15.onf.100-102 · Cited by 1
Investigation and management of pancreatic tumours
Smith, L., Jamieson, N. B., & McKay, C. J. (2013) · Frontline Gastroenterology · doi:10.1136/flgastro-2013-100364 · Cited by 1
Controversy on the time to progression of pancreatic ductal adenocarcinoma
Gallmeier, E., Hernáez, R., & Gress, T. M. (2015) · Gut · doi:10.1136/gutjnl-2014-309066 · Cited by 1
Pathology and Molecular Pathology of Pancreatic Cancer
Foo, W. C., & Wang, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_26 · Cited by 1
A current picture of genetic counseling for familial pancreatic cancer
Sampson, J. E., & Hamman, K. J. (2016) · Expert Review of Quality of Life in Cancer Care · doi:10.1080/23809000.2016.1255552 · Cited by 1
Multiparameter Modalities for the Study of Patients in the Setting of Individualized Medicine
Miyabayashi, K., Tuveson, D. A., & Yu, K. H. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_65 · Cited by 1
PRECiSE: PancREatic Cancer Prioritization and Screening Evaluation Tool.
Abu-El-Haija, L. (2019) · NCSU Libraries Repository (North Carolina State University Libraries) · Cited by 1
Pancreatic cancer screening — is it prime time yet?
Bruno, M. J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0221-z · Cited by 1
Self-citationMatsubayashi, H., Notohara, K., Hruban, R. H., Satoh, T., Kaneko, J., Sato, J., Ishiwatari, H., Ashida, R., Uesaka, K., Kiyozumi, Y., et al. (2020) · Internal Medicine · doi:10.2169/internalmedicine.3882-19 · Cited by 1
Self-citationFatores prognósticos pré-operatórios em pacientes com adenocarcinoma ductal da cabeça do pâncreas
Rodrigues, J. B. S. R., Campanati, R. G., Lima, L. D. P., Rubião, F., de-Freitas, J. C., de-Melo, F. H. C., Machado, C. J., Sanches, M. D., & Resende, V. (2020) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20202363 · Cited by 1
Hereditary Syndromes and Pancreatic Cancer
Pölsler, L., Claes, K., & Zschocke, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_3 · Cited by 1
Frühdiagnose des Pankreaskarzinoms – Die Rolle von Endosonografie und Sonografie
Schorr, F., & Essig, M. W. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1515-3123 · Cited by 1
Langer, P., & Bartsch, D. K. (2013) · Springer eBooks · doi:10.1007/978-3-642-37964-2_63 · Cited by 1
Secondary Screening for Inherited Pancreatic Ductal Adenocarcinoma
Sheel, A., Nicholson, J., Sarantitis, I., Neoptolemos, J. P., & Greenhalf, W. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_63 · Cited by 1
Characteristics of familial pancreatic cancer families with additional colorectal carcinoma
Lehman, B., Matthäi, E., Krasser‐Gercke, N., Denzer, U. W., Figiel, J. H., Hess, T., Slater, E. P., & Bartsch, D. K. (2023) · Familial Cancer · doi:10.1007/s10689-023-00328-1 · Cited by 1
Familial pancreatic cancer: a long fruitful journey
Brentnall, T. A. (2024) · Familial Cancer · doi:10.1007/s10689-024-00364-5 · Cited by 1
Vilà-Quintana, L., Fort, E., Pardo, L., Albiol-Quer, M. T., Ortiz, M., Capdevila, M., Feliu, A., Bahí, A., Llirós, M., Aguilar, E., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082247 · Cited by 2
Surgical aspects related to hereditary pancreatic cancer
Maurer, E., & Bartsch, D. K. (2024) · Familial Cancer · doi:10.1007/s10689-024-00384-1 · Cited by 1
Elder, M. M., Mbous, Y. P. V., Rudisill, T. M., & Kelley, G. A. (2024) · Health Sciences Review · doi:10.1016/j.hsr.2024.100203 · Cited by 1
Concerns Regarding the Utility of High-Risk Pancreatic Cancer Surveillance—Reply
Blackford, A. L., Canto, M. I., & Goggins, M. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.5522 · Cited by 1
Self-citationPancreatic Cancer in Hereditary Breast and Ovarian Cancer Syndrome: Is Early Detection Possible?
Abe, K., Kitago, M., Kobayashi, Y., Masuda, K., Seki, T., Yamada, M., Goto, Y., Ono, I., Misu, K., Nakamura, K., et al. (2025) · The Keio Journal of Medicine · doi:10.2302/kjm.2024-0018-oa · Cited by 1
Screening Strategies for Pancreatic Cancer in High-Risk Patients
Talamonti, M. S. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.0391 · Cited by 1
Mughetti, M., Calculli, L., Chiesa, A. M., Ciccarese, F., Rrusho, O., & Pezzilli, R. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0421-8 · Cited by 1
DNA Mismatch Repair and Lynch Syndrome
Razvi, M. A., Giardiello, F. M., & Law, J. K. (2017) · Current Colorectal Cancer Reports · doi:10.1007/s11888-017-0366-5 · Cited by 1
Screening of Pancreatic Cancer.
Saif, M. W. (2018) · PubMed · Cited by 1
Screening for Pancreatic Cancer in Individuals With New-onset Diabetes Mellitus
Lo, T. (2018) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2018.07.010 · Cited by 1
Clementine, R., Mas, L., Granier, S., Colle, E., Neuzillet, C., & Hammel, P. R. (2019) · Cancer Reports and Reviews · doi:10.15761/crr.1000184 · Cited by 1
Hereditary Gastrointestinal Cancers
Thirumurthi, S., Vilar, E., & Lynch, P. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-18890-0_33 · Cited by 1
Hot Topic: Should all Women with Breast Cancer Undergo Genetic Testing?
Wood, M. E., & Bedrosian, I. (2019) · Current Breast Cancer Reports · doi:10.1007/s12609-019-00343-1 · Cited by 1
Familial Predisposition and Genetic Risk Factors Associated with Pancreatic Cancer
Rustgi, S. D., Hilfrank, K. J., & Kastrinos, F. (2021) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2021.09.001 · Cited by 1
がん早期診断・リスク層別化，精密医療に資するバイオマーカー探索と社会実装を目指して
本田, 一. (2021) · Nihon Ika Daigaku Igakkai Zasshi · doi:10.1272/manms.17.146 · Cited by 1
Jesus‐Acosta, A. D., Narang, A. K., Mauro, L. A., Herman, J. M., Jaffee, E. M., & Laheru, D. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00078-5 · Cited by 1
the Society of PhySicianS of hong Kong
Wai, K., & Keung, L. W. (2012) · Cited by 1
Screening first-degree relatives for gastric cancer prevention
Lachter, J. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.08.010 · Cited by 1
Gutierrez, O. I. B., & Lennon, A. M. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.01.023 · Cited by 1
Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?—Response
Caldwell, K. E., & Hammill, C. W. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0257 · Cited by 1
Hodgson, S. V., Foulkes, W. D., Eng, C., & Maher, E. R. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2375-0_5 · Cited by 1
Jia, K., Kundrot, S., Palchuk, M. B., Warnick, J., Haapala, K., Kaplan, I. D., Rinard, M., & Appelbaum, L. (2023) · medRxiv · doi:10.1101/2023.02.05.23285192 · Cited by 1
Bestari, M. B., Joewono, I. R., & Syam, A. F. (2023) · Preprints.org · doi:10.20944/preprints202312.2276.v1
Neuzillet, C. (2018) · theses.fr (ABES) · doi:10.70675/71b3d021zb0eaz45a4z95a5zdb254dc5bde0 · Cited by 1
The Emerging Genetic Basis and Its Clinical Implication in Pancreatic Cancer
Chen, F., Guo, Y., & Wang, L. (2015) · Gastrointestinal Tumors · doi:10.1159/000435764
Findet die molekulare Diagnostik Einzug in die Pankreaspathologie?
Sipos, B., & Sperveslage, J. (2013) · Der Pathologe · doi:10.1007/s00292-013-1865-z
Tang, R. S. Y. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12232
Familial Pancreatic Cancer: To Screen or not to Screen?
Vasen, H. F. A., & Bartsch, D. K. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.014
Merino, L. A., Aldeguer-Martínez, M., Lozano-Maya, M., Hernández-García-Gallardo, D., & Casado‐Fariñas, I. (2015) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2015.06.004
Merino, L. A., Aldeguer-Martínez, M., Lozano-Maya, M., Hernández-García-Gallardo, D., & Casado‐Fariñas, I. (2015) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2015.08.002
The role of genetic variation in predisposition to alcohol-related chronic pancreatitis
Johnstone, M. (2016) · University of Liverpool · doi:10.17638/02037520
Obermair, F., Popper, U., Romeder, F., & Rumpold, H. F. (2016) · Wiener klinisches Magazin · doi:10.1007/s00740-016-0107-4 · Cited by 1
Les nouvelles maladies pancréatiques à la lumière de l'imagerie
Lévy, P. (2012) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31655-3
Evaluation and Surveillance Strategies for Patients at Increased Risk of Pancreatic Cancer
Nayor, J., Grover, S., & Syngal, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-19677-0_15
How to Manage Cystic Tumors of the Pancreas in High-Risk Individuals
Konings, I. C. A. W., Cahen, D. L., & Bruno, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-31882-0_14
Self-citationDiagnosis and Staging of Pancreatic Malignancies
Chawla, S., Mekaroonkamol, P., & Willingham, F. F. (2015) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814618991_0014
Mori, H., & Yamada, Y. (2015) · Pancreatic Disorders and Therapy · doi:10.4172/2165-7092.1000161
L’adénocarcinome du pancréas : du diagnostic au traitement
Frampas, É., David, A., Régenet, N., Touchefeu, Y., Meyer, J. F., & Morla, O. (2016) · Journal de radiologie diagnostique et interventionnelle · doi:10.1016/j.jradio.2016.07.007
Facteurs prédisposants de l’adénocarcinome pancréatique : quel est le rôle de l’imagerie ?
Vullierme, M., & Lagadec, M. (2016) · Journal de radiologie diagnostique et interventionnelle · doi:10.1016/j.jradio.2016.10.003
Pancreas Adenocarcinoma and Ampullary Cancer
Barnes, C. A., Christians, K. K., Evans, D. B., & Tsai, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-28089-9_6
Screening and Prevention of Extra Colonic Cancer in Hereditary Non-polyposis Colorectal Cancer
Mittal, R., & Arulampalam, T. (2015) · GI surgery annual · doi:10.1007/978-981-10-2010-0_3
EUS and Its Role in Pancreatic Cancer
Grote, T., & Gress, T. M. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_79-1
Borazanci, E. H., & Haag, S. (2017) · InTech eBooks · doi:10.5772/65067
Yoo, L., & Levenick, J. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-53091-8_11
Neoplasia of the Gastrointestinal Tract
Margalit, O., & DuBois, R. N. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch31
Secondary Screening for Inherited Pancreatic Ductal Adenocarcinoma
Sheel, A., Nicholson, J., Sarantitis, I., Neoptolemos, J. P., & Greenhalf, W. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_63-1
Martinelli, P., & Lonardo, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804003-4.00007-4
Screening for Pancreatic Cancer: Who to Screen and How to Follow-Up?
Hart, P. A., Stanich, P. P., & Hampel, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-58256-6_4
Advanced Endoscopic Procedures
Farrell, J. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-58256-6_8
Pancreatic Cancer Screening: Attempts and Possibilities
Mourad, M. M., Evans, R. P. T., Aly, E. A., Fisher, S. G., Dvorkin, L. S., & Bramhall, S. R. (2017) · Journal of Hepatology and Gastrointestinal disorders · doi:10.4172/2475-3181.1000151
Screening for Subsequent Pancreatic Cancer in Childhood Cancer Survivors is Needed. A Case Report
Zaletel, L. Z., Cavlek, M., & Gjidera, M. (2017) · Journal of Nuclear Medicine & Radiation Therapy · doi:10.4172/2155-9619.1000348
Adenocarcinoma of the Pancreas
Chu, Q. D., Borazanci, E. H., Kim, R. H., & Sangster, G. P. (2018) · doi:10.1002/9781118592168.ch6
Screening of Patients with Hereditary Pancreatic Cancer
Goggins, M. (2018) · Wiley eBooks · doi:10.1002/9781119188421.ch98
Self-citationGenetic Predisposition to Gastric Cancer: CDH1 and Beyond
Hakkaart, C. (2018) · Otago University Research Archive (University of Otago)
Pankreaskarzinom: Klinik, Labordiagnostik und bildgebende Diagnostik
Mai, C., & Lutz, M. P. (2019) · Springer Reference Medizin · doi:10.1007/978-3-642-54676-1_123-2
Surveillance Guidelines for Hereditary Colorectal Cancer Syndromes
Stjepanovic, N., Moreira, L., Balmañà, J., & Brunet, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-74259-5_20
Poorly differentiated ductal adenocarcinoma of the pancreas with rapid progression in a young man
Tezuka, K., Ishiyama, T., Takeshita, A., Matsumoto, H., Jingu, A., Kikuchi, J., Yamaya, H., Ohe, R., & Ishizawa, T. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-018-0859-z
Evaluation and Staging of Pancreaticobiliary Malignancy
Levy, M., & Al-Haddad, M. A. (2019) · Clinical Gastrointestinal Endoscopy · doi:10.1016/b978-0-323-41509-5.00062-1
Self-citationModel to Stratify Risk of Pancreatic Cancer in Patients Diagnosed as New-onset Diabetes
Kim, S. B. (2018) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2018.72.3.159
Ager, C. R. (2018) · Digital Commons-TMC (Texas Medical Center)
Analysis of postoperative course after pancreatic resections – experience of one centre
Głuszek, S., Kot, M., Matykiewicz, J., Nawacki, Ł., Wawrzycka, I., Kozłowska-Geller, M. A., Kołomańska, M., Kuchinka, J., Zieliński, P., Głuszek–Osuch, M., et al. (2018) · Medical Studies · doi:10.5114/ms.2018.80948
Loon, K. V., & Tempero, M. A. (2014) · doi:10.1002/9781118589199.ch89
Holtzman, N. A., & Probst-Hensch, N. M. (2018) · Public Health Genomics · doi:10.1159/000499051
The Role of Endoscopic Ultrasound in Early Detection of Pancreatic Cancer
Ko, S. W., Hwang, J. S., & Song, T. J. (2019) · The Korean Journal of Pancreas and Biliary Tract · doi:10.15279/kpba.2019.24.3.102
Genetic Counseling for Pancreatic Cancer
Geurts, J. L. (2019) · Springer eBooks · doi:10.1007/978-3-319-98944-0_13
Rangelova, E. B. (2019) · Figshare
Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling
Webster, R. D., Bannon, S. A., Hyde, S. M., Woodson, A., You, N., Lu, K. H., & Arun, B. (2019) · Wiley eBooks · doi:10.1002/9781119000822.hfcm143
Metadata
- Authors
- Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., Levy, M. J., Chak, A., Fockens, P., Goggins, M., & Bruno, M.
- Affiliations
- Johns Hopkins University (US)
- Erasmus MC (NL)
- Utrecht University (NL)
- Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
- Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
- University of Verona (IT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Mayo Clinic (US)
- University Hospitals of Cleveland (US)
- Corresponding author
- Canto, Marcia Irene
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2012-11-07
- Volume
- 62
- Issue
- 3
- Pages
- 339-347
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC3585492
- OpenAlex
- W2111705409
- Cited by
- 784
- References
- 88
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 40 · 2023: 53 · 2022: 66 · 2021: 73 · 2020: 61 · 2019: 82 · 2018: 82 · 2017: 67 · 2016: 71 · 2015: 69 · 2014: 45 · 2013: 23 · 2012: 6
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Update notices
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Cancer Institute (K24CA113433, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic cancer screening, familial pancreatic cancer, genetic susceptibility, pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, Peutz-Jeghers syndrome, BRCA2 mutation carriers, Lynch syndrome, endoscopic ultrasound, surveillance interval, surgical management, high-volume centers, multidisciplinary team, consensus recommendations
- MeSH terms
- Age Factors, Carcinoma, Follow-Up Studies, Humans, Mutation, Pancreatectomy, Pancreatic Neoplasms, Pedigree, Risk Factors, Treatment Outcome, Endosonography, Genetic Predisposition to Disease, Cholangiopancreatography, Magnetic Resonance, Early Detection of Cancer, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
